This fact justifies the higher splenic plasma cell level in the L3 treatment than that in the N3 treatment (Figure 4F), as the L3 treatment produces both anti-influenza IgG and IgA, while the N3 treatment mostly induces IgG production only (Figure 5A,B). Here, CD79A is linked to influenza.